Goldstein Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Goldstein Advisors's MRK Position: Q3 2026 in Review
Goldstein Advisors increased its Merck (MRK) stake by 41% in Q3 2026, buying an estimated $252K and bringing the position to 6,258 shares worth $909K. The position accounts for 0.08% of the portfolio, ranked #89.
Goldstein Advisors first reported a position in MRK in Q4 2022 and has held it in 16 quarters since. 2,589 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Goldstein Advisors held 6,258 shares of Merck worth $909K as of Q3 2026.
- Goldstein Advisors bought 1,824 Merck shares in Q3 2026, an estimated $252K.
- Merck made up 0.08% of Goldstein Advisors's portfolio in Q3 2026, its #89 holding.
- Goldstein Advisors first reported a position in Merck in Q4 2022 and has held it in 16 quarters since.
- 2,589 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Goldstein Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.